Anti-FLT3 (domain 5) Neutralizing Antibody (V3S-0522-YC556) (CAT#: V3S-0522-YC556)

Send Inquiry
  • fig1
    Figure 1 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SDS-PAGE
  • fig1
    Figure 2 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB
  • fig1
    Figure 3 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SEC-HPLC
  • fig1
    Figure 4 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB
  • fig1
    Figure 5 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Fms Related Tyrosine Kinase 3. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Epitope The epitope is domain 5 of FLT3.
Isotype IgG1, κ

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; ELISA; Neut
Application Notes The antibody is recommended for detection of FLT3 by ELISA, Neut assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target FLT3
Alternative Name Fms Related Tyrosine Kinase 3; Stem Cell Tyrosine Kinase 1; Fms-Like Tyrosine Kinase 3; FL Cytokine Receptor; CD135 Antigen; EC 2.7.10.1; CD135; FLK-2; STK1; FLK2;
Gene ID 2322
UniProt P36888
Research Area Immunology
Related Disease Acute myeloid leukemia

Tested Data

SDS-PAGE

Figure 1 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SDS-PAGE

SDS-PAGE analysis of V3S-0522-YC556 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as about 180 kDa.

Figure 1 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SDS-PAGE

WB

Figure 2 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB

Western blot analysis of V3S-0522-YC556 was performed by loading 2 µg onto a 12% Tris-HCl polyacrylamide gel in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with Goat Anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for 75 minutes. Chemiluminescent detection was performed.

Figure 2 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB

HPLC

Figure 3 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SEC-HPLC

The purity of V3S-0522-YC556 was greater than 90% as determined by SEC-HPLC.

Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.3
Detection: UV 280 nm
Injection: 25 µl

Figure 3 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in SEC-HPLC

WB

Figure 4 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB

Western blot analysis was performed by loading 1 µg (lane 1) and 1 µg (lane 2) recombinant human FLT3 antigen onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with TLT3 antibody (V3S-0522-YC556) at a dilution of 1:1000 overnight at 4°C on a rocking platform. Then probed with Goat anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.

Figure 4 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in WB

ELISA

Figure 5 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in ELISA

ELISA analysis of V3S-0522-YC556 was performed by coating with recombinant human FLT3 antigen. Then blocked with BSA, and incubated with TLT3 antibody (V3S-0522-YC556) at a starting concentration of 1µg/mL. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 5 Anti-FLT3 Monoclonal Antibody (V3S-0522-YC556) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry